A novel radiosensitiser for cancer radiotherapy

TECHNOLOGY

UNDER CONSTRACTION

OUR PIPELINE

UNDER CONSTRACTION

OUR TEAM

The execution team

Kazuhiko Tawara

Vice President Business Development

The execution team

Shogo Yamashita

Vice President Product Development

The execution team

Toshihide Itoh

Vice President Clinical Development

The BoD members

Yoshizo Hatta

GM Sojitz Corporation

The BoD members

Kenichi Nagai

CEO BrightPath Biotherapeutics Co., Ltd.

Scientific Advisors

Dr. Michihiko Wada

Professor of Keio University

Scientific AdvisorsThe BoD members

Bob Kneller MD

Emeritus Professor of University of Tokyo

Inventor of KORTUC

Dr. Yasuhiro Ogawa

Emeritus Professor of Kochi University